212 related articles for article (PubMed ID: 20067707)
1. Strategies to prolong the intravaginal residence time of drug delivery systems.
Baloglu E; Senyigit ZA; Karavana SY; Bernkop-Schnürch A
J Pharm Pharm Sci; 2009; 12(3):312-36. PubMed ID: 20067707
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive and thermogelling systems for vaginal drug delivery.
Caramella CM; Rossi S; Ferrari F; Bonferoni MC; Sandri G
Adv Drug Deliv Rev; 2015 Sep; 92():39-52. PubMed ID: 25683694
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs.
de Araújo PR; Calixto GMF; da Silva IC; de Paula Zago LH; Oshiro Junior JA; Pavan FR; Ribeiro AO; Fontana CR; Chorilli M
AAPS PharmSciTech; 2019 Jun; 20(6):225. PubMed ID: 31214798
[TBL] [Abstract][Full Text] [Related]
4. Vaginal mucoadhesive drug delivery systems.
de Araújo Pereira RR; Bruschi ML
Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
[TBL] [Abstract][Full Text] [Related]
5. In situ gelling and mucoadhesive polymers: why do they need each other?
Zahir-Jouzdani F; Wolf JD; Atyabi F; Bernkop-Schnürch A
Expert Opin Drug Deliv; 2018 Oct; 15(10):1007-1019. PubMed ID: 30173567
[TBL] [Abstract][Full Text] [Related]
6. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA.
Furst T; Dakwar GR; Zagato E; Lechanteur A; Remaut K; Evrard B; Braeckmans K; Piel G
J Control Release; 2016 Aug; 236():68-78. PubMed ID: 27329774
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
8. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
Wong TW; Dhanawat M; Rathbone MJ
Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
[TBL] [Abstract][Full Text] [Related]
9. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
[TBL] [Abstract][Full Text] [Related]
10. Vaginal Delivery of Benzydamine Hydrochloride through Liposomes Dispersed in Mucoadhesive Gels.
Tuğcu-Demiröz F
Chem Pharm Bull (Tokyo); 2017 Jul; 65(7):660-667. PubMed ID: 28442642
[TBL] [Abstract][Full Text] [Related]
11. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
[TBL] [Abstract][Full Text] [Related]
12. Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems.
Pereira MN; Reis TA; Matos BN; Cunha-Filho M; Gratieri T; Gelfuso GM
Colloids Surf B Biointerfaces; 2017 Oct; 158():222-228. PubMed ID: 28697437
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive vaginal drug delivery systems.
Acartürk F
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):193-205. PubMed ID: 19925443
[TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive microspheres: a promising tool in drug delivery.
Patil SB; Sawant KK
Curr Drug Deliv; 2008 Oct; 5(4):312-8. PubMed ID: 18855602
[TBL] [Abstract][Full Text] [Related]
16. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy.
Andersen T; Bleher S; Eide Flaten G; Tho I; Mattsson S; Škalko-Basnet N
Mar Drugs; 2015 Jan; 13(1):222-36. PubMed ID: 25574737
[TBL] [Abstract][Full Text] [Related]
17. Vaginal residence and pharmacokinetic preclinical study of topical vaginal mucoadhesive W/S emulsions containing ciprofloxacin.
Campaña-Seoane M; Pérez-Gago A; Vázquez G; Conde N; González P; Martinez A; Martínez X; García Varela L; Herranz M; Aguiar P; Fernández-Ferreiro A; Laguna R; Otero-Espinar FJ
Int J Pharm; 2019 Jan; 554():276-283. PubMed ID: 30423417
[TBL] [Abstract][Full Text] [Related]
18. Emerging Trends and Potential Prospects in Vaginal Drug Delivery.
Mahant S; Sharma AK; Gandhi H; Wadhwa R; Dua K; Kapoor DN
Curr Drug Deliv; 2023; 20(6):730-751. PubMed ID: 35422213
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application.
Furst T; Piette M; Lechanteur A; Evrard B; Piel G
Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):128-35. PubMed ID: 25660908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
